94 related articles for article (PubMed ID: 10909992)
1. Indomethacin decreases insulin secretion in patients with type 2 diabetes mellitus.
Pereira Arias AM; Romijn JA; Corssmit EP; Ackermans MT; Nijpels G; Endert E; Sauerwein HP
Metabolism; 2000 Jul; 49(7):839-44. PubMed ID: 10909992
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin does not affect endogenous glucose production in type 2 diabetes mellitus.
Pereira Arias AM; Bisschop PH; Ackermans MT; Endert E; Romijn JA; Sauerwein HP
Horm Metab Res; 2001 Nov; 33(11):659-63. PubMed ID: 11733868
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin stimulates glucose production in adults with uncomplicated falciparum malaria.
Dekker E; Romijn JA; Huynh ; Ackermans MT; Endert E; Kager PA; Thuy LT; Sauerwein HP
Metabolism; 1998 Feb; 47(2):217-22. PubMed ID: 9472974
[TBL] [Abstract][Full Text] [Related]
4. Aminophylline stimulates insulin secretion in patients with type 2 diabetes mellitus.
Arias AM; Bisschop PH; Ackermans MT; Nijpels G; Endert E; Romijn JA; Sauerwein HP
Metabolism; 2001 Sep; 50(9):1030-5. PubMed ID: 11555834
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin stimulates basal glucose production in humans without changes in concentrations of glucoregulatory hormones.
Corssmit EP; Romijn JA; Endert E; Sauerwein HP
Clin Sci (Lond); 1993 Dec; 85(6):679-85. PubMed ID: 8287659
[TBL] [Abstract][Full Text] [Related]
6. Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?
Radziuk J; Pye S
Diabetologia; 2006 Jul; 49(7):1619-28. PubMed ID: 16752180
[TBL] [Abstract][Full Text] [Related]
7. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
Mevorach M; Giacca A; Aharon Y; Hawkins M; Shamoon H; Rossetti L
J Clin Invest; 1998 Aug; 102(4):744-53. PubMed ID: 9710443
[TBL] [Abstract][Full Text] [Related]
8. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Toft I; Jenssen T
Scand J Clin Lab Invest; 2005; 65(4):307-20. PubMed ID: 16076686
[TBL] [Abstract][Full Text] [Related]
9. On the role of the gut in diabetic hyperglucagonaemia.
Lund A
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
[TBL] [Abstract][Full Text] [Related]
10. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.
Boden G; Chen X; Stein TP
Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E23-30. PubMed ID: 11120655
[TBL] [Abstract][Full Text] [Related]
11. Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy.
Magnussen LV; Glintborg D; Hermann P; Hougaard DM; Højlund K; Andersen M
Diabetes Obes Metab; 2016 Oct; 18(10):980-9. PubMed ID: 27265844
[TBL] [Abstract][Full Text] [Related]
12. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
Christensen MB
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
[TBL] [Abstract][Full Text] [Related]
13. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
Jazet IM; Pijl H; Frölich M; Romijn JA; Meinders AE
Metabolism; 2005 Jun; 54(6):705-12. PubMed ID: 15931603
[TBL] [Abstract][Full Text] [Related]
14. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes.
Basu R; Schwenk WF; Rizza RA
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E55-62. PubMed ID: 14982753
[TBL] [Abstract][Full Text] [Related]
15. Regulation of endogenous glucose production after a mixed meal in type 2 diabetes.
Singhal P; Caumo A; Carey PE; Cobelli C; Taylor R
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E275-83. PubMed ID: 12110532
[TBL] [Abstract][Full Text] [Related]
16. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
[TBL] [Abstract][Full Text] [Related]
17. Modulation of glucose production by indomethacin and pentoxifylline in healthy humans.
Corssmit EP; Romijn JA; Endert E; Sauerwein HP
Metabolism; 1996 Dec; 45(12):1458-65. PubMed ID: 8969277
[TBL] [Abstract][Full Text] [Related]
18. Resistance training enhances insulin suppression of endogenous glucose production in elderly women.
Honka MJ; Bucci M; Andersson J; Huovinen V; Guzzardi MA; Sandboge S; Savisto N; Salonen MK; Badeau RM; Parkkola R; Kullberg J; Iozzo P; Eriksson JG; Nuutila P
J Appl Physiol (1985); 2016 Mar; 120(6):633-9. PubMed ID: 26744506
[TBL] [Abstract][Full Text] [Related]
19. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
20. Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus.
Mevorach M; Kaplan J; Chang CJ; Rossetti L; Shamoon H
Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E421-9. PubMed ID: 10710496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
